157 related articles for article (PubMed ID: 36451863)
1. m
Liu R; Zhong Y; Chen R; Chu C; Liu G; Zhou Y; Huang Y; Fang Z; Liu H
Theranostics; 2022; 12(18):7760-7774. PubMed ID: 36451863
[No Abstract] [Full Text] [Related]
2. Identification of miR-30c-5p as a tumor suppressor by targeting the m
Wu Q; Li G; Gong L; Cai J; Chen L; Xu X; Liu X; Zhao J; Zeng Y; Gao R; Yu L; Wang Z
Cancer Med; 2023 Feb; 12(4):5055-5070. PubMed ID: 36259156
[TBL] [Abstract][Full Text] [Related]
3. HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.
Jiang F; Tang X; Tang C; Hua Z; Ke M; Wang C; Zhao J; Gao S; Jurczyszyn A; Janz S; Beksac M; Zhan F; Gu C; Yang Y
J Hematol Oncol; 2021 Apr; 14(1):54. PubMed ID: 33794982
[TBL] [Abstract][Full Text] [Related]
4. HNRNPA2B1 inhibited SFRP2 and activated Wnt-β/catenin via m6A-mediated miR-106b-5p processing to aggravate stemness in lung adenocarcinoma.
Rong L; Xu Y; Zhang K; Jin L; Liu X
Pathol Res Pract; 2022 May; 233():153794. PubMed ID: 35364458
[TBL] [Abstract][Full Text] [Related]
5. Integrative Analysis of NSCLC Identifies LINC01234 as an Oncogenic lncRNA that Interacts with HNRNPA2B1 and Regulates miR-106b Biogenesis.
Chen Z; Chen X; Lei T; Gu Y; Gu J; Huang J; Lu B; Yuan L; Sun M; Wang Z
Mol Ther; 2020 Jun; 28(6):1479-1493. PubMed ID: 32246902
[TBL] [Abstract][Full Text] [Related]
6. Activation of the HNRNPA2B1/
Sun M; Shen Y; Jia G; Deng Z; Shi F; Jing Y; Xia S
J Cancer; 2023; 14(7):1242-1256. PubMed ID: 37215455
[TBL] [Abstract][Full Text] [Related]
7. HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma.
Jia C; Guo Y; Chen Y; Wang X; Xu Q; Zhang Y; Quan L
J Transl Med; 2022 Nov; 20(1):537. PubMed ID: 36401285
[TBL] [Abstract][Full Text] [Related]
8. hnRNPA2B1 Associated with Recruitment of RNA into Exosomes Plays a Key Role in Herpes Simplex Virus 1 Release from Infected Cells.
Zhou X; Wang L; Zou W; Chen X; Roizman B; Zhou GG
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295924
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma.
Yang J; He J; Wang J; Cao Y; Ling J; Qian J; Lu Y; Li H; Zheng Y; Lan Y; Hong S; Matthews J; Starbuck MW; Navone NM; Orlowski RZ; Lin P; Kwak LW; Yi Q
Leukemia; 2012 Sep; 26(9):2114-23. PubMed ID: 22425892
[TBL] [Abstract][Full Text] [Related]
10. HNRNPA2B1 Is a Mediator of m(6)A-Dependent Nuclear RNA Processing Events.
Alarcón CR; Goodarzi H; Lee H; Liu X; Tavazoie S; Tavazoie SF
Cell; 2015 Sep; 162(6):1299-308. PubMed ID: 26321680
[TBL] [Abstract][Full Text] [Related]
11. Transthyretin affects the proliferation and migration of human retinal microvascular endothelial cells in hyperglycemia via hnRNPA2B1.
Gu Y; Hu D; Xin Y; Shao J
Biochem Biophys Res Commun; 2021 Jun; 557():280-287. PubMed ID: 33894415
[TBL] [Abstract][Full Text] [Related]
12. hnRNPA2B1 inhibits the exosomal export of miR-503 in endothelial cells.
Pérez-Boza J; Boeckx A; Lion M; Dequiedt F; Struman I
Cell Mol Life Sci; 2020 Nov; 77(21):4413-4428. PubMed ID: 31894362
[TBL] [Abstract][Full Text] [Related]
13. HNRNPA2B1-Mediated MicroRNA-92a Upregulation and Section Acts as a Promising Noninvasive Diagnostic Biomarker in Colorectal Cancer.
Li Y; Li K; Lou X; Wu Y; Seery S; Xu D; Pei Y; Qian B; Wu Y; Liang S; Wu K; Cui W
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831695
[TBL] [Abstract][Full Text] [Related]
14. Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway.
Hu Y; Sun Z; Deng J; Hu B; Yan W; Wei H; Jiang J
Tumour Biol; 2017 Mar; 39(3):1010428317694318. PubMed ID: 28351333
[TBL] [Abstract][Full Text] [Related]
15. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs.
Villarroya-Beltri C; Gutiérrez-Vázquez C; Sánchez-Cabo F; Pérez-Hernández D; Vázquez J; Martin-Cofreces N; Martinez-Herrera DJ; Pascual-Montano A; Mittelbrunn M; Sánchez-Madrid F
Nat Commun; 2013; 4():2980. PubMed ID: 24356509
[TBL] [Abstract][Full Text] [Related]
16. Linc02349 promotes osteogenesis of human umbilical cord-derived stem cells by acting as a competing endogenous RNA for miR-25-3p and miR-33b-5p.
Cao L; Liu W; Zhong Y; Zhang Y; Gao D; He T; Liu Y; Zou Z; Mo Y; Peng S; Shuai C
Cell Prolif; 2020 May; 53(5):e12814. PubMed ID: 32346990
[TBL] [Abstract][Full Text] [Related]
17. HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells.
Klinge CM; Piell KM; Tooley CS; Rouchka EC
Sci Rep; 2019 Jul; 9(1):9430. PubMed ID: 31263129
[TBL] [Abstract][Full Text] [Related]
18. GATA4-driven miR-206-3p signatures control orofacial bone development by regulating osteogenic and osteoclastic activity.
Guo S; Gu J; Ma J; Xu R; Wu Q; Meng L; Liu H; Li L; Xu Y
Theranostics; 2021; 11(17):8379-8395. PubMed ID: 34373748
[TBL] [Abstract][Full Text] [Related]
19. Osteoclast-derived miR-23a-5p-containing exosomes inhibit osteogenic differentiation by regulating Runx2.
Yang JX; Xie P; Li YS; Wen T; Yang XC
Cell Signal; 2020 Jun; 70():109504. PubMed ID: 31857240
[TBL] [Abstract][Full Text] [Related]
20. MiR-1-3p regulates the differentiation of mesenchymal stem cells to prevent osteoporosis by targeting secreted frizzled-related protein 1.
Gu H; Shi S; Xiao F; Huang Z; Xu J; Chen G; Zhou K; Lu L; Yin X
Bone; 2020 Aug; 137():115444. PubMed ID: 32447074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
